| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |